Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

Buyers
Jabil Inc.
Targets
Pharmaceutics International (Pii)
Sellers
Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital, Pharmascience Inc.
Industry
Pharmaceuticals
Location
Maryland, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.